Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Aleix Cases;

Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;

Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus Alberto Ortiz; Ana Cebrián; Alfonso Soto; Andrés Reyes; Jose Luis Górriz;